DTE Energy (NYSE:DTE) reported quarterly adj. earnings of $1.31 per share which beat the analyst consensus estimate of $1.24 by 5.65 percent. This is a 24.76 percent increase over earnings of $1.05 per share from the same period last year.
Preclinical Ketamine Trial Shows Positive Results For Pain Conditions Like Fibromyalgia And Arthritis
Biotech psychedelics researcher and developer Silo Pharma Inc. (OTCQB: SILO) announced its topically-administered proprietary ketamine obtained a positive outcome in a recent preclinical study.